Regarding "Transcriptional and Cytokine Profiles Identify CXCL9 as a Biomarker of Disease Activity in Morphea"

J Invest Dermatol. 2018 May;138(5):1212-1215. doi: 10.1016/j.jid.2017.11.032. Epub 2017 Dec 12.
No abstract available

Publication types

  • Comment

MeSH terms

  • Biomarkers
  • Humans
  • Scleroderma, Localized*

Substances

  • Biomarkers